United States International Trade Commision Rulings And Harmonized Tariff Schedule
faqs.org  Rulings By Number  Rulings By Category  Tariff Numbers
faqs.org > Rulings and Tariffs Home > Rulings By Number > 2003 NY Rulings > NY I89736 - NY I89779 > NY I89764

Previous Ruling Next Ruling
NY I89764




January 21, 2003

CLA-2-29:RR:NC:2:238 I89764

CATEGORY: CLASSIFICATION

TARIFF NO.: 2933.59.3600

Ms. Iliana G. Fuller
Allergan, Inc.
2525 Dupont Drive
P.O. Box 19534
Irvine, CA 92623-9534

RE: The tariff classification of Gatifloxacin (CAS-180200-66-2), imported in bulk form, from Japan

Dear Ms. Fuller:

In your letter dated January 7, 2003, you requested a tariff classification ruling.

The subject product, Gatifloxacin, is a synthetic, broad-spectrum, antibacterial agent. Chemically, Gatifloxacin is (±) -1-cyclopropyl-6-fluoro-1,4-diydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid, sesquihydrate.

The applicable subheading for Gatifloxacin, imported in bulk form will be 2933.59.3600, Harmonized Tariff Schedule of the United States (HTS), which provides for “Heterocyclic compounds with nitrogen hetero-atom(s) only: Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure: Other: Drugs: Aromatic or modified aromatic: Anti-infective agents: Other.” Pursuant to General Note 13, HTS, the rate of duty will be free.

This merchandise may be subject to the requirements of the Federal Food, Drug, and Cosmetic Act, which is administered by the U.S. Food and Drug Administration. You may contact them at 5600 Fishers Lane, Rockville, Maryland 20857, telephone number 301-443-1544.

This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177).

A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at 646-733-3033.

Sincerely,

Robert B. Swierupski

Previous Ruling Next Ruling

See also: